InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,721.83
(
-0.19%
)
US TECH 100
19,420.40
(
0.03%
)
Dow Jones
41,924.80
(
-0.67%
)
Brent Oil
73.02
(
-2.07%
)
Bitcoin
63,321.32
(
-1.47%
)
Post# of 253221
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: None

Tuesday, 06/02/2020 8:27:58 AM

Tuesday, June 02, 2020 8:27:58 AM

Post# of 253221
$MNLO Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105 for the Treatment of Moderate-to-Severe Acne Vulgaris


https://www.globenewswire.com/news-release/2020/06/02/2042185/0/en/Menlo-Therapeutics-Announces-Positive-Results-from-Phase-2-Trial-of-FCD105-for-the-Treatment-of-Moderate-to-Severe-Acne-Vulgaris.html

IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up